Key figures

  • Sales

    10,741 € million

    9,906 € million

    +8.4%

  • EBITDA pre one-time items

    2,965 € million

    2,724 € million

    +8.9%

  • Free cash fl ow

    2,040 € million

    1,436 € million

    +42.0%

Merck Annual Report 2012

  • Karl-Ludwig Kley – Chairman of the Executive Board (Photo)

    “Our goal is to transform Merck into a faster and more efficient company that delivers profitable growth through its innovative pharmaceutical, chemical and life science businesses.“

    Letter from Karl-Ludwig Kley

  • Our shared ideas connect us. They are changing our company.

    Road to tomorrow

  • Here you can find our interactive Chart tool and all Downloads.

    Chart GeneratorDownloads

5-YEAR OVERVIEW

Key developments of the last five years at a glance.

Dynamic table

IMPORTANT CONTENTS

SERVICES

Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2013/03/07